よむ、つかう、まなぶ。

MC plus(エムシープラス)は、診療報酬・介護報酬改定関連のニュース、

資料、研修などをパッケージした総合メディアです。


参考資料4_Action plan for whole genome analysis 2022 (10 ページ)

公開元URL https://www.mhlw.go.jp/stf/newpage_33324.html
出典情報 厚生科学審議会 科学技術部会全ゲノム解析等の推進に関する専門委員会(第15回 5/25)《厚生労働省》
低解像度画像をダウンロード

資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。

(3) The type of medical care that whole genome analysis promotion aims for
The present project aims for medical care that will overcome cancer and
rare/intractable diseases in the future by promoting whole genome analysis that will
accumulate data strategically and by facilitating the use of these data in research
and drug discovery to deliver high-quality medical care to the citizens.
In addition, the present project will further promote the early introduction of the
results of analysis into clinical practice and the implementation of new, personalized
medical care.
*In the present Action Plan, the term “cancer” refers to intractable cancers, rare
cancers, pediatric cancers, hereditary cancers, and other types of cancer for which
whole genome analysis is expected to have a certain effect, but for which the private
sector alone cannot conduct research and drug discovery.

Figure 3. The type of medical care that whole genome analysis promotion aims for

2. Objectives of the Project
In analyses that have been carried out to date, the analysis results have been
introduced to clinical practice at an early stage and have been used in the promotion
of new, personalized medical care.

9

ページ内で利用されている画像ファイルです。